Andexxa

Showing 1 posts of 1 posts found.

AstraZeneca’s phase 4 trial stopped early after reaching pre-specified criteria

June 5, 2023
Research and Development ANNEXA-I, Andexxa, AstraZeneca, Neurology, clinical trial

AstraZeneca has announced that its post-marketing phase 4 ANNEXA-I trial has been stopped early after reaching its pre-specified stopping criteria. …

Latest content